FDA Inspection 1191449 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1373023

The FDA completed an inspection of American Red Cross Blood Services on November 7, 2022 in Liverpool, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Liverpool, NY (United States)